Haemonetics Corporation
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $1.11B | $1.86B | $259.5M |
| FY2023 | $1.12B | $1.93B | $284.5M |
| FY2024 | $1.24B | $2.20B | $178.8M |
| FY2025 | $1.63B | $2.45B | $306.8M |
| FY2026 | $1.60B | $2.40B | $245.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $1.11B | $1.86B | $259.5M |
| FY2023 | $1.12B | $1.93B | $284.5M |
| FY2024 | $1.24B | $2.20B | $178.8M |
| FY2025 | $1.63B | $2.45B | $306.8M |
| FY2026 | $1.60B | $2.40B | $245.4M |